A share price of BeOne Medicines Ltd ADR [ONC] is currently trading at $269.7, up 6.96%. An important factor to consider is whether the stock is rising or falling in short-term value. The ONC shares have gain 10.32% over the last week, with a monthly amount drifted -2.47%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BeOne Medicines Ltd ADR [NASDAQ: ONC] stock has seen the most recent analyst activity on April 07, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $312. Previously, BofA Securities upgraded its rating to Buy on March 03, 2025, and elevated its price target to $320. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $288 on September 18, 2024. Macquarie started tracking with a Outperform rating for this stock on September 12, 2023, and assigned it a price target of $259. In a note dated August 17, 2023, Jefferies initiated an Buy rating and provided a target price of $287 on this stock.
BeOne Medicines Ltd ADR experienced fluctuations in its stock price throughout the past year between $146.21 and $287.88. Currently, Wall Street analysts expect the stock to reach $303.5 within the next 12 months. BeOne Medicines Ltd ADR [NASDAQ: ONC] shares were valued at $269.7 at the most recent close of the market. An investor can expect a potential return of 12.53% based on the average ONC price forecast.
Analyzing the ONC fundamentals
Trailing Twelve Months sales for BeOne Medicines Ltd ADR [NASDAQ:ONC] were 4.18B which represents 48.64% growth. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -0.07%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.07, Equity is -0.12 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 265.69 points at the first support level, and at 261.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 271.85, and for the 2nd resistance point, it is at 274.01.
Ratios To Look Out For
To put it in perspective, the Current Ratio for BeOne Medicines Ltd ADR [NASDAQ:ONC] is 1.96. On the other hand, the Quick Ratio is 1.71, and the Cash Ratio is 1.27. Considering the valuation of this stock, the price to sales ratio is 7.08, the price to book ratio is 8.32.
Transactions by insiders
Recent insider trading involved OYLER JOHN, Chief Executive Officer, that happened on Jul 09 ’25 when 27802.0 shares were sold. Director, JOHN V OYLER completed a deal on Jul 09 ’25 to buy 27802.0 shares. Meanwhile, Director PAN-OYLER FOUNDATION bought 1661.0 shares on Jul 08 ’25.
